← Leaderboards
Robert S Langer
Massachusetts Institute Of Technology
$47,407,448
Attributed
$56,163,544
Total exposure
26
Grants
17
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8.6M · FY2005–23$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$88,011,281 · 28
By mechanism
U54$40,568,382 · 11
R01$38,025,077 · 11
R37$3,932,088 · 1
R24$3,510,668 · 1
RC1$1,975,066 · 2
U19$0 · 2
Top collaborators
- Michael J Cima9 shared
- Ann M Graybiel5 shared
- Carlo Giovanni Traverso4 shared
- Forest M White4 shared
- Daniel G Anderson3 shared
- Klavs F Jensen2 shared
- Clark K Colton1 shared
Most similar at Massachusetts Institute Of Technology
Same institution · by research overlap
- Michael B Yaffe$28,748,219
- Daniel G Anderson$11,913,058
- Klavs F Jensen$1,018,304
- Jianzhu Chen$19,874,531
- Gareth H McKinley$943,838
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoPolymersTechnologyDrug Delivery SystemsTissuesBasePharmaceutical PreparationsGrantPropertyIn VitroEngineeringCellsAreaPerformanceDesignStructureFundingNanotechnologySciencePublishingBiomaterial CompatibilitySurfaceMalignant NeoplasmsAnimal Model
Grant awards (142)
Micro-invasive biochemical sampling of brain interstitial fluid for investigating neural pathology$624,325
R01 · FY2023 · EB · contact PI
Micro-invasive biochemical sampling of brain interstitial fluid for investigating neural pathology$625,925
R01 · FY2022 · EB · contact PI
A new high-throughput gastrointestinal tract explant platform for drug formulation discovery and metabolic disease modulation$1,068,674
R01 · FY2021 · EB · contact PI
Micro-invasive biochemical sampling of brain interstitial fluid for investigating neural pathology$614,927
R01 · FY2021 · EB · contact PI
A new high-throughput gastrointestinal tract explant platform for drug formulation discovery and metabolic disease modulation$1,057,438
R01 · FY2020 · EB · contact PI
Micro-invasive biochemical sampling of brain interstitial fluid for investigating neural pathology$628,550
R01 · FY2020 · EB · contact PI
A new high-throughput gastrointestinal tract explant platform for drug formulation discovery and metabolic disease modulation$1,030,151
R01 · FY2019 · EB · contact PI
Novel Polymers for Tissue Engineering$390,000
R01 · FY2019 · DE · contact PI
A new high-throughput gastrointestinal tract explant platform for drug formulation discovery and metabolic disease modulation$1,024,309
R01 · FY2018 · EB · contact PI
Novel Polymers for Tissue Engineering$390,000
R01 · FY2018 · DE · contact PI
A New Device for Electrical & Chemical Modulation of Pathological Neural Activity$1,107,394
R01 · FY2017 · EB · contact PI
Controlled Release of Macromolecules$390,000
R37 · FY2017 · EB · contact PI
Novel Polymers for Tissue Engineering$390,000
R01 · FY2017 · DE · contact PI
A New Device for Electrical & Chemical Modulation of Pathological Neural Activity$1,114,877
R01 · FY2016 · EB · contact PI
Controlled Release of Macromolecules$390,000
R37 · FY2016 · EB · contact PI
Novel Polymers for Tissue Engineering$390,000
R01 · FY2016 · DE · contact PI
A New Device for Electrical & Chemical Modulation of Pathological Neural Activity$1,092,794
R01 · FY2015 · EB · contact PI
Novel Polymers for Tissue Engineering$390,000
R01 · FY2015 · DE · contact PI
Controlled Release of Macromolecules$382,200
R37 · FY2015 · EB · contact PI
MIT-Harvard Center of Cancer Nanotechnology Excellence$2,212,567
U54 · FY2014 · CA · contact PI
A New Device for Electrical & Chemical Modulation of Pathological Neural Activity$1,087,170
R01 · FY2014 · EB · contact PI
Targeted Nanoparticles for Tempospatially Controlled Combination Chemotherapy$905,712
U54 · FY2014 · CA · contact PI
Novel Polymers for Tissue Engineering$399,585
R01 · FY2014 · DE · contact PI
High-Throughput Craniofacial tissue engineering$395,010
R01 · FY2014 · DE · contact PI
Controlled Release of Macromolecules$378,300
R37 · FY2014 · EB · contact PI
Administrative Core$102,325
U54 · FY2014 · CA · contact PI
Developmental Activities$77,624
U54 · FY2014 · CA · contact PI
Education/Training and Outreach Activities$42,340
U54 · FY2014 · CA · contact PI
MIT-Harvard Center of Cancer Nanotechnology Excellence$2,213,478
U54 · FY2013 · CA · contact PI
A New Device for Electrical & Chemical Modulation of Pathological Neural Activity$1,127,687
R01 · FY2013 · EB · contact PI
Targeted Nanoparticles for Tempospatially Controlled Combination Chemotherapy$911,048
U54 · FY2013 · CA · contact PI
Controlled Release of Macromolecules$390,000
R37 · FY2013 · EB · contact PI
Novel Polymers for Tissue Engineering$382,187
R01 · FY2013 · DE · contact PI
High-Throughput Craniofacial tissue engineering$379,208
R01 · FY2013 · DE · contact PI
Expanding the Clinical Utility of Ultrasound-Assisted Transdermal Drug Delivery$317,332
R01 · FY2013 · EB · contact PI
Administrative Core$101,878
U54 · FY2013 · CA · contact PI
Developmental Activities$77,285
U54 · FY2013 · CA · contact PI
Education/Training and Outreach Activities$42,155
U54 · FY2013 · CA · contact PI
MIT-Harvard Center of Cancer Nanotechnology Excellence$2,286,947
U54 · FY2012 · CA · contact PI
Targeted Nanoparticles for Tempospatially Controlled Combination Chemotherapy$1,012,220
U54 · FY2012 · CA · contact PI
Controlled Release of Macromolecules$399,667
R37 · FY2012 · EB · contact PI
Novel Polymers for Tissue Engineering$398,481
R01 · FY2012 · DE · contact PI
High-Throughput Craniofacial tissue engineering$395,010
R01 · FY2012 · DE · contact PI
Expanding the Clinical Utility of Ultrasound-Assisted Transdermal Drug Delivery$337,789
R01 · FY2012 · EB · contact PI
Administrative Core$120,588
U54 · FY2012 · CA · contact PI
Developmental Activities$91,480
U54 · FY2012 · CA · contact PI
Education/Training and Outreach Activities$49,898
U54 · FY2012 · CA · contact PI
MIT-Harvard Center of Cancer Nanotechnology Excellence$2,290,029
U54 · FY2011 · CA · contact PI
Microchip Drug Delivery System$1,116,773
R01 · FY2011 · EB · contact PI
Targeted Nanoparticles for Tempospatially Controlled Combination Chemotherapy$938,701
U54 · FY2011 · CA · contact PI
Novel Polymers for Tissue Engineering$406,510
R01 · FY2011 · DE · contact PI
High-Throughput Craniofacial tissue engineering$387,030
R01 · FY2011 · DE · contact PI
Controlled Release of Macromolecules$386,153
R37 · FY2011 · EB · contact PI
Expanding the Clinical Utility of Ultrasound-Assisted Transdermal Drug Delivery$339,007
R01 · FY2011 · EB · contact PI
Administrative Core$105,489
U54 · FY2011 · CA · contact PI
Developmental Activities$80,026
U54 · FY2011 · CA · contact PI
Education/Training and Outreach Activities$43,651
U54 · FY2011 · CA · contact PI
MIT-Harvard Center of Cancer Nanotechnology Excellence$2,295,376
U54 · FY2010 · CA · contact PI
Microchip Drug Delivery System$1,165,106
R01 · FY2010 · EB · contact PI
Human Pluripotent Stem Cell Differentiation with Defined O2 & Protein Engagement$975,069
RC1 · FY2010 · DE
Targeted Nanoparticles for Tempospatially Controlled Combination Chemotherapy$901,531
U54 · FY2010 · CA · contact PI
High throughput cell reprogramming by microfluidic jet injection$499,998
RC1 · FY2010 · EB
Controlled Release of Macromolecules$402,150
R37 · FY2010 · EB · contact PI
High-Throughput Craniofacial tissue engineering$399,000
R01 · FY2010 · DE · contact PI
Novel Polymers for Tissue Engineering$399,000
R01 · FY2010 · DE · contact PI
Expanding the Clinical Utility of Ultrasound-Assisted Transdermal Drug Delivery$353,896
R01 · FY2010 · EB · contact PI
Administrative Core$108,751
U54 · FY2010 · CA · contact PI
Developmental Activities$82,500
U54 · FY2010 · CA · contact PI
Education/Training and Outreach Activities$45,000
U54 · FY2010 · CA · contact PI
The MIT-Harvard Center of Cancer Nanotechnology Excelle*$4,121,187
U54 · FY2009 · CA · contact PI
Microchip Drug Delivery System$1,179,974
R01 · FY2009 · EB · contact PI
TARGETED POLYMERIC NANOPARTICLES FOR CANCER THERAPY$614,343
U54 · FY2009 · CA · contact PI
High throughput cell reprogramming by microfluidic jet injection$499,999
RC1 · FY2009 · EB
Controlled Release of Macromolecules$406,614
R37 · FY2009 · EB · contact PI
Craniofacial tissue engineering with human embryonic and adult derived stem cells$369,782
R01 · FY2009 · DE · contact PI
Novel Polymers for Tissue Engineering$363,848
R01 · FY2009 · DE · contact PI
EDUCATION, TRAINING, AND OUTREACH CORE$361,133
U54 · FY2009 · CA · contact PI
PILOT STUDIES$226,574
U54 · FY2009 · CA · contact PI
ADMINISTRATIVE CORE$221,169
U54 · FY2009 · CA · contact PI
The MIT-Harvard Center of Cancer Nanotechnology Excelle*$200,001
U54 · FY2009 · CA · contact PI
The MIT-Harvard Center of Cancer Nanotechnology Excelle*$4,313,570
U54 · FY2008 · CA · contact PI
Microchip Drug Delivery System$1,182,925
R01 · FY2008 · EB · contact PI
TARGETED POLYMERIC NANOPARTICLES FOR CANCER THERAPY$415,731
U54 · FY2008 · CA · contact PI
Controlled Release of Macromolecules$407,004
R37 · FY2008 · EB · contact PI
Craniofacial tissue engineering with human embryonic and adult derived stem cells$369,782
R01 · FY2008 · DE · contact PI
Novel Polymers for Tissue Engineering$363,848
R01 · FY2008 · DE · contact PI
Vascularization of engineered cardiac tissue$335,495
R01 · FY2008 · HL · contact PI
EDUCATION, TRAINING, AND OUTREACH CORE$243,436
U54 · FY2008 · CA · contact PI
Ultrasonic Drug Delivery Via Localized Transport Regions$229,163
R01 · FY2008 · EB · contact PI
PILOT STUDIES$152,730
U54 · FY2008 · CA · contact PI
ADMINISTRATIVE CORE$149,286
U54 · FY2008 · CA · contact PI
The MIT-Harvard Center of Cancer Nanotechnology Excelle*$3,928,266
U54 · FY2007 · CA · contact PI
Microchip Drug Delivery System$1,141,030
R01 · FY2007 · EB · contact PI
Craniofacial tissue engineering with human embryonic and adult derived stem cells$374,285
R01 · FY2007 · DE · contact PI
Novel Polymers for Tissue Engineering$367,894
R01 · FY2007 · DE · contact PI
Vascularization of engineered cardiac tissue$335,884
R01 · FY2007 · HL · contact PI
Controlled Release of Macromolecules$333,518
R01 · FY2007 · EB · contact PI
Ultrasonic Drug Delivery Via Localized Transport Regions$233,840
R01 · FY2007 · EB · contact PI
The MIT-Harvard Center of Cancer Nanotechnology Excelle*$3,968,892
U54 · FY2006 · CA · contact PI
Craniofacial tissue engineering with human embryonic an*$379,142
R01 · FY2006 · DE · contact PI
Novel Polymers for Tissue Engineering$378,882
R01 · FY2006 · DE · contact PI
Vascularization of engineered cardiac tissue$346,301
R01 · FY2006 · HL · contact PI
Controlled Release of Macromolecules$343,479
R01 · FY2006 · EB · contact PI
Ultrasonic Drug Delivery Via Localized Transport Regions$240,824
R01 · FY2006 · EB · contact PI
The MIT-Harvard Center of Cancer Nanotechnology Excelle*$4,017,424
U54 · FY2005 · CA
Novel Polymers for Tissue Engineering$388,000
R01 · FY2005 · DE
Craniofacial tissue engineering with human &adult ESCs$383,692
R01 · FY2005 · DE
Controlled Release of Macromolecules$351,745
R01 · FY2005 · EB
Vascularization of engineered cardiac tissue$350,820
R01 · FY2005 · HL
Ultrasonic Drug Delivery Via Localized Transport Regions$246,619
R01 · FY2005 · EB
Controlled Release of Macromolecules$351,745
R01 · FY2004 · EB
Ultrasound Polymeric Drug Delivery$230,861
R01 · FY2004 · EB
MICROCHIP DRUG DELIVERY SYSTEM$933,759
R24 · FY2003 · AI
ANGIOGENESIS INHIBITORS FROM SHARK CARTILAGE$355,500
R01 · FY2003 · AT
CONTROLLED RELEASE OF MACROMOLECULES$291,280
R01 · FY2003 · EB
Ultrasound Polymeric Drug Delivery$230,861
R01 · FY2003 · EB
MICROCHIP DRUG DELIVERY SYSTEM$801,006
R24 · FY2002 · AI
ANGIOGENESIS INHIBITORS FROM SHARK CARTILAGE$355,500
R01 · FY2002 · AT
PHOTOPOLYMERIZATION FOR NONINVASIVE CARTILAGE TISSUE$327,000
R01 · FY2002 · DE
BIOMATERIALS FOR CARDIOVASCULAR TISSUE ENGINEERING SCAFF$327,000
R01 · FY2002 · HL
CONTROLLED RELEASE OF MACROMOLECULES$291,280
R01 · FY2002 · EB
Ultrasound Polymeric Drug Delivery$230,861
R01 · FY2002 · EB
IMMUNIZATION VEHICLES FOR SPERM ANTIGENS$165,579
U54 · FY2002 · HD
BIOMATERIALS FOR CARDIOVASCULAR TISSUE ENGINEERING SCAFF$82,750
R01 · FY2002 · HL
DEVELOPMENT OF CONTROLLED-RELEASE POLYMERS$0
U19 · FY2002 · CA
MICROCHIP DRUG DELIVERY SYSTEM$899,016
R24 · FY2001 · AI
ANGIOGENESIS INHIBITORS FROM SHARK CARTILAGE$353,849
R01 · FY2001 · AT
PHOTOPOLYMERIZATION FOR NONINVASIVE CARTILAGE TISSUE$327,000
R01 · FY2001 · DE
BIOMATERIALS FOR CARDIOVASCULAR TISSUE ENGINEERING SCAFF$327,000
R01 · FY2001 · HL
CONTROLLED RELEASE OF MACROMOLECULES$288,347
R01 · FY2001 · GM
Ultrasound Polymeric Drug Delivery$256,368
R01 · FY2001 · GM
IMMUNIZATION VEHICLES FOR SPERM ANTIGENS$165,579
U54 · FY2001 · HD
DEVELOPMENT OF CONTROLLED-RELEASE POLYMERS$0
U19 · FY2001 · CA
MICROCHIP DRUG DELIVERY SYSTEM$876,887
R24 · FY2000 · AI
BIOMATERIALS FOR CARDIOVASCULAR TISSUE ENGINEERING SCAFF$408,640
R01 · FY2000 · HL
PHOTOPOLYMERIZATION FOR NONINVASIVE CARTILAGE TISSUE$327,000
R01 · FY2000 · DE
CONTROLLED RELEASE OF MACROMOLECULES$287,760
R01 · FY2000 · GM
IMMUNIZATION VEHICLES FOR SPERM ANTIGENS$164,883
U54 · FY2000 · HD
ULTRASONIC POLYMERIC DRUG DELIVERY$58,558
R01 · FY2000 · GM
DEVELOPMENT OF CONTROLLED-RELEASE POLYMERS$0
U19 · FY2000 · CA
DEVELOPMENT OF CONTROLLED-RELEASE POLYMERS$0
U19 · FY2000 · CA
DEVELOPMENT OF CONTROLLED-RELEASE POLYMERS$0
U19 · FY2000 · CA